We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
+21.34%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+385.76%
AUM
$344B
AUM Growth
+$54.6B
Cap. Flow
+$157M
Cap. Flow %
0.05%
Top 10 Hldgs %
15.97%
Holding
7,323
New
372
Increased
3,332
Reduced
2,355
Closed
316
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOT icon
5826
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$507M
$4K ﹤0.01%
90
-117
-57% -$5.75K
VWO icon
5827
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$4K ﹤0.01%
281
-1,600
-85% -$59.2K
WRN
5828
Western Copper and Gold
WRN
$542M
$4K ﹤0.01%
5,130
WTW icon
5829
PUT
Willis Towers Watson
WTW
$32.1B
$4K ﹤0.01%
2,200
XTL icon
5830
State Street SPDR S&P Telecom ETF
XTL
$587M
$4K ﹤0.01%
63
XWEL icon
5831
XWELL
XWEL
$8.95M
$4K ﹤0.01%
52
+51
+5,100% +$2.68K
CSCI
5832
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$4K ﹤0.01%
50
+42
+525% +$3.84K
ASXC
5833
DELISTED
Asensus Surgical, Inc.
ASXC
$4K ﹤0.01%
7,646
-40,113
-84% -$19.4K
SBOW
5834
DELISTED
SilverBow Resources, Inc.
SBOW
$4K ﹤0.01%
1,129
-24,658
-96% -$99.6K
ORTX
5835
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$4K ﹤0.01%
70
TESS
5836
DELISTED
Tessco Technologies Inc
TESS
$4K ﹤0.01%
807
-15,719
-95% -$83.4K
STON
5837
DELISTED
StoneMor Inc.
STON
$4K ﹤0.01%
4,621
-367
-7% -$253
HPR
5838
DELISTED
HighPoint Resources Corporation
HPR
$4K ﹤0.01%
225
-1,987
-90% -$28.8K
CCR
5839
DELISTED
CONSOL Coal Resources LP
CCR
$4K ﹤0.01%
1,001
+90
+10% +$424
GMO
5840
DELISTED
General Moly, Inc.
GMO
$4K ﹤0.01%
20,540
+4
+0% +$1
CVIA
5841
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$4K ﹤0.01%
9,041
-49,442
-85% -$27K
DBV
5842
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$4K ﹤0.01%
180
FRAK
5843
DELISTED
VanEck Vectors Unconventional Oil & Gas ETF
FRAK
$4K ﹤0.01%
59
-10,825
-99% -$665K
FCAN
5844
DELISTED
First Trust Canada AlphaDEX Fund
FCAN
$4K ﹤0.01%
201
ACRS icon
5845
Aclaris Therapeutics
ACRS
$853M
$3K ﹤0.01%
2,236
-50,114
-96% -$67.1K
ALT icon
5846
Altimmune
ALT
$595M
$3K ﹤0.01%
288
+201
+231% +$1.1K
ATHE
5847
Alterity Therapeutics
ATHE
$82.3M
$3K ﹤0.01%
250
BRF icon
5848
VanEck Brazil Small-Cap ETF
BRF
$21.5M
$3K ﹤0.01%
201
-1,050
-84% -$15.6K
MBAI
5849
Check-Cap
MBAI
$10.8M
$3K ﹤0.01%
250
+175
+233% +$2.21K
CLDX icon
5850
Celldex Therapeutics
CLDX
$3.31B
$3K ﹤0.01%
251
-79
-24% -$350

Similar funds

Wells Fargo's Q2 2020 Portfolio in Review

As of Q2 2020, Wells Fargo held 7,323 positions worth $344B, up 19% from $289B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wells Fargo's Q2 2020 filing shows 372 new, 3,332 increased, 2,355 reduced and 316 closed positions. Its largest new stake was Otis Worldwide: 1,752,089 shares worth $99.6M. The largest sale was iShares Russell 2000 ETF, an estimated $644M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Wells Fargo's largest Q2 2020 buy was Otis Worldwide: 1,752,089 shares worth $99.6M.
  • Wells Fargo added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $1.35B increase.
  • Wells Fargo's biggest Q2 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $644M.
  • Wells Fargo fully exited Allergan plc in Q2 2020, selling an estimated $251M.
  • Wells Fargo's ten largest holdings make up 16% of its $344B portfolio in Q2 2020.
  • Wells Fargo opened 372 new positions and closed 316 in Q2 2020.
  • Wells Fargo's portfolio value rose 19% quarter-over-quarter to $344B.

Based on Wells Fargo's 13F filing for Q2 2020, filed 13 Aug 2020.